SLC2A4 and obesity due to melanocortin 4 receptor deficiency: We found a reduction of GLUT4 content in heart of MSG-treated SHR at the age of 3, 6 and 9 months, which can be explained by the hypothesis that the reduction of this transporter in the heart occurs when obesity and insulin resistance are established [41].